To include your compound in the COVID-19 Resource Center, submit it here.

RESprotect, RedHill deal

RedHill received a one-year option from RESprotect to acquire exclusive, worldwide rights to RP101 for all indications,

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE